Delivery Order SPE2DB24D2106-SPE2DB25FAWMT
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was awarded a delivery order valued at $1,989.25 by the Defense Logistics Agency (DLA) on July 23, 2025. This firm fixed-price contract calls for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 24, 2025. The award was made without a set-aside designation, allowing the company to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) with a ceiling value of $2,217.66. The award, finalized on September 10, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.48 to DMS Pharmaceutical Group Inc. for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents a single product delivery to support federal pharmaceutical supply needs. The place of performance is listed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a ceiling value of $2,412.14 and a completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that specializes in providing a range of pharmaceutical products to federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,314.20, is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has a period of performance through May 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,440.48 contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in a 150 ml bottle. The contract has an ultimate completion date of March 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract...
- This is a $1,427.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,231.66 by the Defense Logistics Agency on August 12, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The contract carries no set-aside designation and is scheduled for completion by August 13, 2025, with performance to take place in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,366.07 contract is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) with a performance period ending on May 20, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, 120 ml, with a ceiling value of $3,379.20 and a completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWMTDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 17, 2025, by the Defense Logistics Agency for Quillivant XR 25 mg/5 ml suspension (120 ml) with a ceiling value of $4,346.15. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and performance will occur in Conshohocken, Pennsylvania. This award was made without a set-aside designation, allowing the vendor to compete directly in the federal procurement market. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price orders for pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities. Quillivant XR is a prescription medication used in the treatment of attention-deficit/hyperactivity disorder, and this particular delivery order represents one of numerous pharmaceutical product orders the vendor fulfills to support military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/17/25 |